Foundation site previewWordPress review draft

Therapeutic nutrition. Metabolic medicine.

Chronic low-grade inflammation is a secret killer. Cellular senescence may be an underlying cause.

Since 2003, the Inflammation Research Foundation has supported research into dietary approaches to reducing inflammation. This research has led to an integrated dietary program, Metabolic Engineering®, designed to reprogram metabolic pathways to help reduce cellular senescence. Senescent cells generate chronic low-grade inflammation, a key contributor to chronic disease and aging.

A New Understanding of the Cause of Chronic Disease: an iceberg depicts aging, neurological disease, heart disease, diabetes, autoimmune disease, and cancer above the surface, with cellular senescence beneath

Increased cellular senescence: The enemy within the body.

Chronic disease may be driven in part by increasing metabolic damage associated with a growing population of senescent cells.

Conceptual violet cell with a cyan nucleus releasing a few amber inflammatory signals.

A cell becomes damaged and signals for its removal

It stops dividing and begins releasing pro-inflammatory signals that can alert the immune system to remove it. This is critical for successful wound repair and suppression of tumor growth.

Conceptual cell surrounded by a larger buildup of amber inflammatory signals.

Inflammatory signals persist with aging

As the immune system ages, it becomes less responsive to these pro-inflammatory signals, leading to increased chronic low-grade inflammation—a process known as inflammaging.

Conceptual neighboring cells with amber signaling particles extending between them.

Surrounding tissue becomes negatively affected

If senescent cells are not removed, their inflammatory signals can drive nearby cells into senescence. This cycle fuels chronic low-grade inflammation, strongly contributing to chronic disease and accelerated aging.

Learn more about Senescent cells

Cellular senescence is associated with numerous chronic conditions.

Our research is exploring the connection between cellular senescence and the conditions below.

Click a condition to learn more.

These chronic conditions may be mitigated with a powerful, integrated dietary technology called Metabolic Engineering®, which can help reverse chronic low-grade inflammation driven by increased cellular senescence. The potential effect of Metabolic Engineering® on these conditions is the core of the IRF's continuing research mission.

What is Metabolic Engineering®?

Metabolic Engineering® is an integrated nutritional system designed to alter metabolic pathways. It comprises several synergistic metabolic interventions: the 4 Rs.

Reduce inflammation induced by senescent cells.

Resolve the inflammation caused by senescent cells.

Remove damaged senescent cells by activating the immune system

Renew damaged tissue by stimulating stem cells to provide new functional cells to replace the removed senescent cells.

Learn more about Metabolic Engineering.

Why Metabolic Engineering® Can Succeed Where Other Pharmaceutical Approaches May Not

We are not the only ones targeting cellular senescence. Early attempts to treat cellular senescence with combinations of cancer drugs and polyphenols have failed in human clinical trials. New proposed technologies such as vaccines, AI-designed peptides, and antibody-drug conjugates follow standard pharmaceutical thinking: one drug, one target.

Metabolic Engineering® is based on modulating synergistic interactions among metabolic pathways using nutrition. In particular, reducing cytokine-based inflammation by activating AMPK via calorie restriction using a precise protein-to-carbohydrate ratio for improved hormonal responses, resolving lipid-based inflammation by increasing the production of powerful hormones known as resolvins by using high-dose omega-3 fatty acids, removing senescent cells using resolvin-based modulation of the immune system, and finally renewing the tissue by stimulating stem cells to produce new replacement cells through the combined actions of resolvins and mTOR.

How Metabolic Engineering® Could Complement Existing Treatments

Conceptual illustration of cyan and gold pathways converging around a violet cell.

GLP‑1 therapies such as semaglutide can help people lose weight, in part by reducing appetite and calorie intake.

Metabolic Engineering® uses nutrition to target pathways involved in inflammation, the removal of senescent cells, and tissue repair. The Inflammation Research Foundation is interested in whether this approach could add to the benefits of medications already in use.

Could combining the two improve outcomes or help patients achieve the same benefit at a lower drug dose? Those are questions for clinical studies.

Dr. Barry Sears
Dr. Barry Sears
President, Inflammation Research Foundation

Dr. Barry Sears, President of the Inflammation Research Foundation

A pioneer in drug delivery technology, now specializing in dietary control of metabolic pathways.

Dr. Barry Sears started one of the first biotechnology companies in the US in 1976. His early work focused on developing new patentable lipid technologies for novel intravenous cancer drug delivery systems. His patented lipids are still used today in cancer drug delivery.

However, after the 1982 Nobel Prize was awarded for recognizing eicosanoids as hormonal mediators of inflammation, he shifted his research to developing dietary technologies to alter these hormones, drawing on his drug-delivery background. That initial work has evolved into the more complex area of reprogramming metabolic pathways to treat chronic diseases associated with cellular senescence.

The Inflammation Research Foundation (IRF) was founded in 2003 to study the relationship between inflammation and chronic disease. Today, the IRF is focused on research to reduce cellular senescence using Metabolic Engineering®.

Read Dr. Barry Sears' CV

Recently published research supported by the IRF

View the complete archive of IRF-supported research

Contact us

If you’re interested in learning more about the potential applications of Metabolic Engineering® to reprogram metabolic pathways, contact us.

info@inflammationresearchfoundation.org
A New Understanding of the Cause of Chronic Disease. An iceberg with chronic conditions above water and cellular senescence beneath.